Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Metabolix Raises Needed Cash

by Alexander H. Tullo
June 29, 2015 | A version of this story appeared in Volume 93, Issue 26

Metabolix, a maker of biobased polyhydroxyalkanoate, has raised $15.0 million through a private placement of stock. Jack W. Schuler of Crabtree Partners, Birchview Capital, and Hong Kong Sino-Science Oil & Gas participated in the round. Schuler and Birchview had previously invested in Meta­bolix. The deal includes options to purchase stock that could net Metabolix another $15.6 million. Metabolix burned through $6.8 million in cash during the first quarter of this year and had only $13.3 million in cash remaining on its balance sheet.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.